Kerastem Technologies LLC reported that the U.S. FDA accepted its 12-month phase II study and the company plans to begin a phase III study of its cell therapy-based hair regrowth system in early 2020 with an as-yet-unidentified distribution partner. Kerastem is a subsidiary of privately held Bimini Technologies LLC, of Solana Beach, Calif.